Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Pharmaceutics|February 19, 2022
Effect of pressure drop on the in vitro dispersion of adhesive mixtures of different blend states for inhalationJonas Rudén, Göran Frenning, Tobias Bramer, et al.
Colloids and Surfaces. B, Biointerfaces|March 17, 2009
Implications of regular solution theory on the release mechanism of catanionic mixtures from gelsTobias Bramer, Göran Frenning, Johan Gråsjö, et al.
Journal of Pharmaceutical Sciences|September 3, 2013
Mechanism of amorphisation of micro-particles of griseofulvin during powder flow in a mixerSamaneh Pazesh, Mina Heidarian Höckerfelt, Jonas Berggren, et al.
Ear and Hearing|January 7, 2009
Middle ear application of a sodium hyaluronate gel loaded with neomycin in a Guinea pig modelAmanj Saber, Göran Laurell, Tobias Bramer, et al.
International Journal of Pharmaceutics|March 3, 2019
Linking carrier morphology to the powder mechanics of adhesive mixtures for dry powder inhalers via a blend-state modelJonas Rudén, Göran Frenning, Tobias Bramer, et al.
Acta Oto-Laryngologica|July 7, 2015
Local treatment of the inner ear: a study of three different polymers aimed for middle ear administrationCecilia Engmér Berglin, Pernilla Videhult Pierre, Andreas Ekborn, et al.
Cancer Chemotherapy and Pharmacology|May 3, 2011
Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig modelCecilia Engmér Berglin, Pernilla Videhult Pierre, Tobias Bramer, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 26, 2013
Magnetic resonance imaging of the middle and inner ear after intratympanic injection of a gadolinium-containing gelCecilia Engmér Berglin, Göran Laurell, Tobias Bramer, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 1, 2022
AZD5634, an inhaled ENaC inhibitor, in healthy subjects and patients with cystic fibrosisCecilia Kristensson, Annika Åstrand, Scott Donaldson, et al.
Pageof 2